EFFECTS OF CELLULAR-TRANSFORMATION ON EXPRESSION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND INHIBITOR-2 - EVIDENCE FOR INDEPENDENT REGULATION

被引：0
|
作者：
COHEN, RL
NICLAS, J
LEE, WMF
WUN, TC
CROWLEY, CW
LEVINSON, AD
SADLER, JE
SHUMAN, MA
机构：
[1] MONSANTO CO, ST LOUIS, MO 63198 USA
[2] WASHINGTON UNIV, SCH MED, HOWARD HUGHES MED INST, ST LOUIS, MO 63110 USA
[3] GENENTECH INC, SAN FRANCISCO, CA 94080 USA
来源：
JOURNAL OF BIOLOGICAL CHEMISTRY | 1989年 / 264卷 / 14期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：8375 / 8383
页数：9
相关论文
共 50 条
  • [41] PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN HUMAN CARCINOMA TISSUES
    TANAKA, N
    FUKAO, H
    UESHIMA, S
    OKADA, K
    YASUTOMI, M
    MATSUO, O
    INTERNATIONAL JOURNAL OF CANCER, 1991, 48 (04) : 481 - 484
  • [42] A MODEL OF THE REACTIVE FORM OF PLASMINOGEN-ACTIVATOR INHIBITOR-1
    AERTGEERTS, K
    DEBONDT, HL
    DERANTER, C
    DECLERCK, PJ
    JOURNAL OF STRUCTURAL BIOLOGY, 1994, 113 (03) : 239 - 245
  • [43] MUTATIONAL AND IMMUNOCHEMICAL ANALYSIS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1
    SHUBEITA, HE
    COTTEY, TL
    FRANKE, AE
    GERARD, RD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1990, 265 (30) : 18379 - 18385
  • [44] EFFECTS OF LOVASTATIN THERAPY ON PLASMINOGEN-ACTIVATOR INHIBITOR-1 ANTIGEN LEVELS
    ISAACSOHN, JL
    SETARO, JF
    NICHOLAS, C
    DAVEY, JA
    DIOTALEVI, LJ
    CHRISTIANSON, DS
    LISKOV, E
    STEIN, EA
    BLACK, HR
    AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (07): : 735 - 737
  • [45] MODULATION OF MESSENGER-RNA LEVELS FOR URINARY-TYPE AND TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND INHIBITOR-2 IN HUMAN-FIBROBLASTS BY INTERLEUKIN 1
    MICHEL, JB
    QUERTERMOUS, T
    JOURNAL OF IMMUNOLOGY, 1989, 143 (03): : 890 - 895
  • [46] BIOLOGICAL EFFECTS OF COMBINED INACTIVATION OF PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE-FUNCTION IN MICE
    LIJNEN, HR
    MOONS, L
    BEELEN, V
    CARMELIET, P
    COLLEN, D
    THROMBOSIS AND HAEMOSTASIS, 1995, 74 (04) : 1126 - 1131
  • [47] STABILITY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1)
    LINDAHL, TL
    SIGURDARDOTTIR, O
    WIMAN, B
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (02) : 748 - 751
  • [48] TGF-BETA INCREASES BOTH UROKINASE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1
    IWASA, M
    HASHIMOTO, K
    MATSUMOTO, K
    HIGASHIYAMA, M
    HASHIRO, M
    UEDA, K
    KIM, K
    NISHIDA, Y
    TAGO, H
    YOSHIKAWA, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 92 (03) : 451 - 451
  • [49] TGF-BETA INCREASES BOTH UROKINASE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1
    IWASA, M
    HASHIMOTO, K
    MATSUMOTO, K
    HIGASHIYAMA, M
    HASHIRO, M
    UEDA, K
    KIM, K
    NISHIDA, Y
    TAGO, H
    YOSHIKAWA, K
    CLINICAL RESEARCH, 1989, 37 (02): : A635 - A635
  • [50] REVERSIBLE INTERACTIONS BETWEEN PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITOR-1
    MIMURO, J
    KANEKO, M
    MURAKAMI, T
    MATSUDA, M
    SAKATA, Y
    BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1160 (03) : 325 - 334
12345